Cowen and Company’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,000
| Closed | -$61.8K | – | 543 |
|
|
2024
Q2 | $61.8K | Sell |
20,000
-30,000
| -60% | -$92.7K | ﹤0.01% | 284 |
|
|
2024
Q1 | $129K | Hold |
50,000
| – | – | 0.01% | 249 |
|
|
2023
Q4 | $125K | Buy |
+50,000
| New | +$125K | 0.01% | 234 |
|
|
2021
Q4 | – | Sell |
-249,215
| Closed | -$1.07M | – | 485 |
|
|
2021
Q3 | $1.07M | Sell |
249,215
-216,102
| -46% | -$927K | 0.05% | 127 |
|
|
2021
Q2 | $1.41M | Sell |
465,317
-21,400
| -4% | -$64.8K | 0.07% | 95 |
|
|
2021
Q1 | $1.62M | Buy |
486,717
+21,400
| +5% | +$71.3K | 0.11% | 91 |
|
|
2020
Q4 | $1.65M | Sell |
465,317
-7,332
| -2% | -$26K | 0.15% | 52 |
|
|
2020
Q3 | $1.48M | Sell |
472,649
-3,858,371
| -89% | -$12.1M | 0.24% | 60 |
|
|
2020
Q2 | $7.88M | Hold |
4,331,020
| – | – | 1.31% | 10 |
|
|
2020
Q1 | $4.37M | Buy |
4,331,020
+3,404,820
| +368% | +$3.44M | 1% | 15 |
|
|
2019
Q4 | $2.58M | Buy |
+926,200
| New | +$2.58M | 0.22% | 42 |
|